
Mikavolk 250mg Injection
Marketer
Medivolks Pharma
Salt Composition
Amikacin (250mg)
Overview Mikavolk 250mg Injection
Cefamandole 250mg Injection is a broad-spectrum antibiotic combating diverse bacterial infections. These encompass urinary tract, bone, and joint infections; lung infections (such as pneumonia); and infections affecting the brain, blood, and other sites. Prophylactic use is also common in hospitalized individuals to avert infection. Cefamandole 250mg Injection inhibits bacterial proliferation. Administered intravenously (IV infusion) or by intramuscular injection under medical supervision, self-administration is strictly prohibited. Consistent dosing, at intervals prescribed by your physician, is crucial. Complete the entire treatment course; premature cessation can result in relapse or exacerbation. Common adverse reactions include injection site inflammation and elevated blood urea nitrogen. Persistent side effects or treatment inefficacy warrant immediate medical consultation. High doses may induce vertigo, renal impairment, and hearing deficits. Strict adherence to your doctor's guidelines is essential, including scheduled kidney function, hearing, and urinalysis. Pregnancy contraindicates this medication; disclose pregnancy, pregnancy intentions, or breastfeeding to your doctor.
Uses of Mikavolk 250mg Injection
Infections caused by bacteria
Major Benefits of Mikavolk 250mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Mikavolk 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Mikavolk 250mg Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strongly discouraged.
How Mikavolk 250mg Injection works:
Mikavolk 250mg injection is a bacterial growth inhibitor, functioning as an antibiotic by disrupting the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
The concomitant use of Mikavolk 250mg Injection and alcohol does not produce adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Mikavolk 250mg Injection during pregnancy is contraindicated due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might consider its use only when potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can generally use Mikavolk 250mg Injection without safety concerns. Research in humans indicates negligible transfer of the medication into breast milk, posing minimal risk to the infant.
DrivingUNSAFE
Administering Mikavolk 250mg Injection may induce drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Caution is advised when administering Mikavolk 250mg Injection to individuals with impaired renal function. Dosage modification of Mikavolk 250mg Injection might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Mikavolk 250mg Injection in patients with liver impairment appears to pose minimal risk. Existing evidence indicates that dosage modification may be unnecessary for this patient group. However, physician consultation is recommended.
What if you forget to take Mikavolk 250mg Injection :
Omit a Mikavolk 250mg Injection dose? Seek your physician's advice.
Facts to Know About Mikavolk 250mg Injection
| Label | Value |
|---|---|
| Chemical Category | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Action Class | Aminoglycoside antibiotics |
